FGEN Fibrogen Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: FGEN

Price (delayed)

$11.72

Market cap

$1.09B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.52

Enterprise value

$837.11M

FibroGen, Inc. is a biopharmaceutical company committed to discovering, developing, and commercializing a pipeline of first-in-class therapeutics. The Company applies its pioneering expertise in hypoxia-inducible factor (HIF) and connective tissue ...

Highlights
The company's revenue has surged by 58% YoY but it fell by 10% QoQ
FGEN's gross profit has surged by 55% year-on-year but it is down by 10% since the previous quarter
The company's debt has surged by 134% YoY
The quick ratio has plunged by 75% YoY and by 35% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.fibrogen.com
Peers: ILMN XLRN HBIO AXDX

Key stats

What are the main financial stats of FGEN
Market
Shares outstanding
92.62M
Market cap
$1.09B
Enterprise value
$837.11M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.14
Price to sales (P/S)
6.29
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.87
Earnings
Revenue
$171.82M
EBIT
-$228.88M
EBITDA
-$208.19M
Free cash flow
-$85.13M
Per share
EPS
-$2.52
Free cash flow per share
-$0.92
Book value per share
$2.83
Revenue per share
$1.86
TBVPS
$8.76
Balance sheet
Total assets
$808.62M
Total liabilities
$528.77M
Debt
$104.94M
Equity
$260.58M
Working capital
$331.7M
Liquidity
Debt to equity
0.4
Current ratio
2.43
Quick ratio
2.28
Net debt/EBITDA
1.19
Margins
EBITDA margin
-121.2%
Gross margin
93.4%
Net margin
-134.7%
Operating margin
-133.8%
Efficiency
Return on assets
-28.6%
Return on equity
-61.5%
Return on invested capital
-117.9%
Return on capital employed
-39.7%
Return on sales
-133.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

FGEN stock price

How has the Fibrogen stock price performed over time
Intraday
0.17%
1 week
-0.59%
1 month
-2.5%
1 year
-73.97%
YTD
-68.4%
QTD
-55.99%

Financial performance

How have Fibrogen's revenue and profit performed over time
Revenue
$171.82M
Gross profit
$160.52M
Operating income
-$229.93M
Net income
-$231.37M
Gross margin
93.4%
Net margin
-134.7%
The company's revenue has surged by 58% YoY but it fell by 10% QoQ
FGEN's gross profit has surged by 55% year-on-year but it is down by 10% since the previous quarter
Fibrogen's operating margin has soared by 55% YoY but it has decreased by 41% from the previous quarter
The company's net margin has surged by 53% YoY but it fell by 40% QoQ

Growth

What is Fibrogen's growth rate over time

Valuation

What is Fibrogen stock price valuation
P/E
N/A
P/B
4.14
P/S
6.29
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.87
The company's EPS rose by 29% YoY but it fell by 25% QoQ
The stock's price to book (P/B) is 52% less than its last 4 quarters average of 8.6 and 50% less than its 5-year quarterly average of 8.3
FGEN's equity is down by 34% year-on-year and by 30% since the previous quarter
The stock's price to sales (P/S) is 69% less than its last 4 quarters average of 20.3 and 69% less than its 5-year quarterly average of 20.1
The company's revenue has surged by 58% YoY but it fell by 10% QoQ

Efficiency

How efficient is Fibrogen business performance
FGEN's return on invested capital has dropped by 127% year-on-year and by 30% since the previous quarter
The company's return on sales has surged by 53% YoY but it fell by 41% QoQ
FGEN's return on equity is down by 38% since the previous quarter but it is up by 3% year-on-year
FGEN's return on assets is down by 27% since the previous quarter but it is up by 22% year-on-year

Dividends

What is FGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for FGEN.

Financial health

How did Fibrogen financials performed over time
FGEN's total assets is 53% greater than its total liabilities
The quick ratio has plunged by 75% YoY and by 35% from the previous quarter
FGEN's current ratio has dropped by 74% year-on-year and by 35% since the previous quarter
The company's debt is 60% lower than its equity
The company's debt has surged by 134% YoY
FGEN's equity is down by 34% year-on-year and by 30% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.